Bipolar disorder is a complex psychiatric disorder, characterized by fluctuations between episodes of (hypo)mania and ...

Bipolar disorder affects 40-50 million people globally, with genetic heritability between 60-80%, and can be triggered by both positive and negative life events, including promotions or new ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

In the largest genome-wide study of bipolar disorder to date, an international team of psychiatric genetics researchers has ...

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

When I shared my bipolar recovery story, many mental health providers doubted that this was possible. Here's how I did ...

The actor best known as a star of Channel 4 's Whose Line Is It Anyway?, passed away on Sunday evening following a heart ...

Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, ...

Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.